Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance

Nature Genetics

Volumn 45, Issue 10, 2013, Pages 1255-1260

  Zhang, Hongtai ^a   Li, Dongfang ^b,c   Zhao, Lili ^d,e   Fleming, Joy ^a   Lin, Nan ^f   Wang, Ting ^a   Liu, Zhangyi ^b   Li, Chuanyou ^g   Galwey, Nicholas ^a   Deng, Jiaoyu ^h   Zhou, Ying ^a   Zhu, Yuanfang ^b   Gao, Yunrong ^a   Wang, Tong ^b   Wang, Shihua ^f   Huang, Yufen ^b   Wang, Ming ^a   Zhong, Qiu ⁱ   Zhou, Lin ⁱ   Chen, Tao ⁱ   Zhou, Jie ^j   Yang, Ruifu ^b   Zhu, Guofeng ^k   Hang, Haiying ^a   Zhang, Jia ^a   Li, Fabin ^l   Wan, Kanglin ^d,e   Wang, Jun ^b   Zhang, Xian En ^a,h   Bi, Lijun ^a   more..

^a INSTITUTE OF BIOPHYSICS   (China)

^b BGI SHENZHEN   (China)

^c Shenzhen Key Laboratory of Unknown Pathogen Identification   (China)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e State Key Laboratory for Infectious Disease Prevention and Control   (China)

^f FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h WUHAN INSTITUTE OF VIROLOGY   (China)

ⁱ Center for Disease Control and Prevention of Guangdong Province   (China)

^j Fourth People's Hospital   (China)

^k Shanghai Municipal Center for Disease Control and Prevention   (China)

^l Heilongjiang Provincial Center for Tuberculosis Prevention and Control   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SPACER DNA;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ASSOCIATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MICROBIAL; GENOME, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84885009252     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2735     Document Type: Article

References (58)

1. Gandhi, N.R., et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375, 1830-1843 (2010).
2. Zumla, A., et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J. Infect. Dis. 205 (suppl. 2), S228-S240 (2012).
3. Goldberg, D.E., Siliciano, R.F. & Jacobs, W.R. Jr. Outwitting evolution: fighting drug-resistant TB, malaria, and HIV. Cell 148, 1271-1283 (2012).
4. Laurenzo, D. & Mousa, S.A. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing. Acta Trop. 119, 5-10 (2011).
5. Zhang, Y. & Yew, W.W. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 13, 1320-1330 (2009).
6. Elena, S.F. & Lenski, R.E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 4, 457-469 (2003).
7. Barrick, J.E., et al. Genome evolution and adaptation in a long-Term experiment with Escherichia coli. Nature 461, 1243-1247 (2009).
8. Woods, R., Schneider, D., Winkworth, C.L., Riley, M.A. & Lenski, R.E. Tests of parallel molecular evolution in a long-Term experiment with Escherichia coli. Proc. Natl. Acad. Sci. USA 103, 9107-9112 (2006).
9. World Health Organization. Global Tuberculosis Control 2011 (World Health Organization, Geneva, 2011).
10. Zhao, Y., et al. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366, 2161-2170 (2012).
11. Ford, C.B. et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat. Genet. 45, 784-790 (2013).
12. Casali, N., et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 22, 735-745 (2012).
13. Walker, T.M., et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 13, 137-146 (2013).
14. Ford, C.B., et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482-486 (2011).
15. Ioerger, T.R., et al. Genome analysis of multi- and extensively-drug- resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE 4, e7778 (2009).
16. Cole, S.T., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
17. Comas, I., et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42, 498-503 (2010).
18. Hershberg, R., et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6, e311 (2008).
19. Gagneux, S. & Small, P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7, 328-337 (2007).
20. Müller, B., Borrell, S., Rose, G. & Gagneux, S. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet. 29, 160-169 (2013).
21. Ramaswamy, S. & Musser, J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79, 3-29 (1998).
22. Sandgren, A., et al. Tuberculosis drug resistance mutation database. PLoS Med. 6, e2 (2009).
23. Sekiguchi, J., et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 45, 179-192 (2007).
24. Zaunbrecher, M.A., Sikes, R.D. Jr., Metchock, B., Shinnick, T.M. & Posey, J.E. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 106, 20004-20009 (2009).
25. World Health Organization. Guidelines for Surveillance of Drug Resistance in Tuberculosis (World Health Organization, Geneva, 2009).
26. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes 4th edn. (World Health Organization, Geneva, 2009).
27. Huang, W., Sherman, B.T. & Lempicki, R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009).
28. Mohanty, D., Sankaranarayanan, R. & Gokhale, R.S. Fatty acyl-AMP ligases and polyketide synthases are unique enzymes of lipid biosynthetic machinery in Mycobacterium tuberculosis. Tuberculosis (Edinb.) 91, 448-455 (2011).
29. Schroeder, E.K., de Souza, N., Santos, D.S., Blanchard, J.S. & Basso, L.A. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Curr. Pharm. Biotechnol. 3, 197-225 (2002).
30. Heath, R.J., White, S.W. & Rock, C.O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467-497 (2001).
31. Birch, H.L., et al. Biosynthesis of mycobacterial arabinogalactan: identification of a novel α(1?3) arabinofuranosyltransferase. Mol. Microbiol. 69, 1191-1206 (2008).
32. Gavalda, S., et al. The Pks13/FadD32 crosstalk for the biosynthesis of mycolic acids in Mycobacterium tuberculosis. J. Biol. Chem. 284, 19255-19264 (2009).
33. Domenech, P., Reed, M.B. & Barry, C.E. III. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect. Immun. 73, 3492-3501 (2005).
34. La Rosa, V., et al. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob. Agents Chemother. 56, 324-331 (2012).
35. Tahlan, K., et al. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56, 1797-1809 (2012).
36. Deidda, D., et al. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains. Antimicrob. Agents Chemother. 42, 3035-3037 (1998).
37. Comas, I., et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106-110 (2012).
38. Ramaswamy, S.V., et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47, 1241-1250 (2003).
39. Rindi, L., et al. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 9, 94-97 (2005).
40. Gagneux, S., et al. Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog. 2, e61 (2006).
41. Fivian-Hughes, A.S., Houghton, J. & Davis, E.O. Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-Aminosalicylic acid. Microbiology 158, 308-318 (2012).
42. Reese, M.G. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput. Chem. 26, 51-56 (2001).
43. Nellen, W. & Hammann, C. Small RNAs: Analysis and Regulatory Functions (Springer, Heidelberg, Germany, 2005).
44. Song, T. & Wai, S.N. A novel sRNA that modulates virulence and environmental fitness of Vibrio cholerae. RNA Biol. 6, 254-258 (2009).
45. Arnvig, K.B., et al. Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis. PLoS Pathog. 7, e1002342 (2011).
46. Miotto, P., et al. Genome-wide discovery of small RNAs in Mycobacterium tuberculosis. PLoS ONE 7, e51950 (2012).
47. Griffin, J.E., et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7, e1002251 (2011).
48. Telenti, A., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647-650 (1993).
49. Koenig, R. Few mutations divide some drug-resistant TB strains. Science 318, 901-902 (2007).
50. Fleischmann, R.D., et al. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184, 5479-5490 (2002).
51. World Health Organization. Policy Guidance on TB Drug Susceptibility Testing (DST) of Second-Line Drugs (World Health Organization, Geneva, 2008).
52. Kamerbeek, J., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35, 907-914 (1997).
53. Demay, C., et al. SITVITWEB-A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect. Genet. Evol. 12, 755-766 (2012).
54. van Soolingen, D., Hermans, P.W., de Haas, P.E., Soll, D.R. & van Embden, J.D. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29, 2578-2586 (1991).
55. Li, R., et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 25, 1966-1967 (2009).
56. Benson, G. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27, 573-580 (1999).
57. Tarailo-Graovac, M. & Chen, N. Using RepeatMasker to identify repetitive elements in genomic sequences. Curr. Protoc. Bioinformatics Chapter 4, Unit 4.10 (2009).
58. Zhang, Z., et al. KaKs Calculator: calculating Ka and Ks through model selection and model averaging. Genomics Proteomics Bioinformatics 4, 259-263 (2006).